Titre:
  • Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology.
Auteur:Gentet, J C; Brunat-Mentigny, M; Demaille, M C; Pein, F; Avet-Loiseau, H; Berger, C; De Lumley, L; Pacquement, H; Schmitt, Christian; Sariban, Eric; Pillon, P; Bernard, J L; Kalifa, C
Informations sur la publication:European journal of cancer, 33, 2, page (232-237)
Statut de publication:Publié, 1997-02
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Bone Neoplasms -- drug therapy
Child
Etoposide -- administration & dosage
Etoposide -- adverse effects
Female
Humans
Ifosfamide -- administration & dosage
Ifosfamide -- adverse effects
Male
Osteosarcoma -- drug therapy
Survival Rate
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase II
Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/S0959-8049(96)00439-X
info:pii/S095980499600439X
info:scp/0030995153
info:pmid/9135494